GO Capital

Go Capital is a management company based in Rennes, France, established in 2003. It is approved by the AMF and is a member of AFIC. The firm focuses on managing over 130 million in assets, primarily investing in early-stage innovative companies with high growth potential in western France.

Margot Boulanger

Senior Associate

Alexandre Boulay

Investment Director

Clementine Breysse

Senior Associate

Frédéric Le Brun

Partner

Salah Chattabi

Associate

Antoine Coutant

Investor

Bertrand Distinguin

Managing Partner

François Fauvin

Associate

Tristan Garde

Associate

Jerome Gueret

Managing Partner

Frédéric Le Guillou

Partner

Aude Kermarrec

Managing Partner

Julien Louis

Senior Associate

Anne Toupé

Investment Director

92 past transactions

Expliseat

Venture Round in 2023
Expliseat combines innovation and manufacturing performance in the lightest aircraft seat in the world: the Titanium Seat. At just 4 kg, this seat reduces fuel consumption considerably, resulting in savings of up to $500,000 per plane per year. And with 10 patents, the Titanium Seat also provides passengers with greater comfort and 2 inches more room, thanks to its unique ergonomic design.

Graftys

Venture Round in 2022
Graftys SAS, based in Aix-en-Provence, France, specializes in the design, development, and manufacturing of synthetic bone biomaterials aimed at reconstructive orthopedic surgery. Founded in 2005, the company provides a range of innovative products, including Graftys QuickSet, a calcium phosphate cement with properties akin to cancellous bone, and biphasic calcium phosphates used for bone repair in surgical procedures. Other offerings include BioActys Granule and Graftys HBS, a cement that transforms into a plastic paste when mixed with a liquid phase. Graftys' products are utilized in various medical applications, such as the fixation of endoprostheses, treatment of bone tumors, and procedures in dentistry and oral surgery, including pulp protection and bone regeneration support.

Healshape

Venture Round in 2022
Operator of a regenerative medicine company intended to develop breast regeneration alternatives by 3D bioprinting. The company develops a bioprosthesis for breast reconstruction, enabling women to regain their self-confidence through natural products and get long-lasting and aesthetic results after the surgery.

Pepette

Series A in 2022
Producer of animal food products and recipes intended to serve cats and dogs. The company offers fresh food: chicken, and beef parameters, made by a veterinary nutritionist, providing customers with recipes as per the requirements of pets.

Pubstack

Series A in 2022
Pubstack is a Paris-based company founded in 2018 that specializes in developing a Software as a Service (SaaS) platform for publishers. The company offers an advertisement monitoring and analytics solution designed to help publishers manage their online promotions effectively. By utilizing modern analytics and automation capabilities, Pubstack enables clients to collect, process, and visualize data related to their advertising activities. This empowers publishers to address complex technical issues at scale, ultimately enhancing their understanding of the factors that influence advertising revenues. Through its platform, Pubstack aims to help publishers maximize the value of their content and improve user experiences.

LeddarTech

Series D in 2022
LeddarTech Inc. is a developer of advanced detection and ranging systems utilizing time-of-flight measurement technology with infrared LEDs. Founded in 2007 and headquartered in Quebec City, Canada, the company offers a range of products, including smart sensor modules for various applications, such as traffic management and industrial use. LeddarTech specializes in environmental sensing platforms, particularly for autonomous vehicles and advanced driver assistance systems (ADAS), enabling customers to address key sensing and perception challenges. Its LeddarVision™ sensor-fusion platform and the LeddarEngine™ for LiDAR development support automotive system integrators in creating comprehensive sensing solutions applicable across multiple mobility sectors, including autonomous shuttles and delivery vehicles. The company holds numerous patents that contribute to innovations in automotive sensing technologies. LeddarTech also provides interconnected sensor solutions for urban infrastructure, public safety, navigation, and agriculture, and sells its products online.

Secure-IC

Venture Round in 2022
Secure-IC, founded in January 2010 by researchers from Télécom ParisTech University, specializes in embedded cybersecurity solutions for embedded systems and connected objects. The company was established by Sylvain Guilley, Jean-Luc Danger, Laurent Sauvage, Hassan Triqui, and Philippe Nguyen, who have extensive expertise in embedded security and hold numerous patents in the field. Secure-IC's offerings focus on safeguarding organizations from cyber-physical attacks by ensuring that optimal security measures are integrated at every stage of the design process. This approach enables clients to effectively protect their sensitive data across various vertical market applications.

Aurora Cold Plasma Sterilisation

Venture Round in 2021
Aurora Cold Plasma Sterilization manufactures medical device sterilizers that use cold plasma. They are the developers of sterilizers intended for the cold sterilization of fragile or complex medical devices. They offer plasma sterilizing devices based on low-pressure air-gas plasma generation. They are involved in the field of sterilization and are supported by committed investors, shareholders, and partners.

Shopopop

Funding Round in 2021
Shopopop is a collaborative delivery platform that facilitates the connection between individuals looking to deliver groceries and those in need of home delivery services. The platform allows users to turn their daily journeys into profitable opportunities by delivering items for others in exchange for a small fee. By linking vendors with customers, Shopopop aims to streamline the process of grocery delivery, ensuring that users receive their purchases conveniently at home without complications. This innovative approach not only enhances local commerce but also promotes a shared economy, benefiting both deliverers and recipients.

Horama SAS

Series B in 2021
Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Babbar

Seed Round in 2021
Developer of a data analytics platform intended to better understand the positioning performance of each web page. The company's platform leverages technology to simulate the algorithmic behavior of a search engine when it browses the web and makes it possible to predict and measure the ability of a site to position itself at the highest point in the search engine results in pages, enabling advertisers to better understand their web page performance.

Diafir

Venture Round in 2021
Diafir develops and manufactures biological testing systems that utilize unique infrared fiber sensor technology for rapid biological analysis. Founded in 2011 and based in Rennes, France, the company focuses on in situ analytical tools that serve key applications in point-of-care medical diagnostics, food analysis, and the monitoring of organic chemical reactions. Diafir's systems are designed to quickly detect conditions such as chronic liver disease, infections, and tumors, achieving results in as little as five minutes. The company's innovative approach leverages chalcogenide fiberglass, enabling effective infrared light transmission for precise and efficient biological analysis.

dessIA

Series A in 2021
Developer of artificial intelligence-augmented engineering software designed to automate engineer's tasks. The company's platform solves engineering problems based on innovative artificial intelligence from a blank sheet to the detailed design of the different components, enabling automotive and mechanical engineers to increase their profit margins and find totally innovative approaches to engineering challenges.

SWEETCH Energy

Venture Round in 2021
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

Velco

Venture Round in 2021
Velco SAS, founded in 2015 and based in Nantes, France, specializes in mobile applications that enhance bicycle security and navigation. The company's flagship product, Wink, is a handlebar device that connects to smartphones, enabling users to track their rides and prevent bike theft. In addition to security features, Velco aims to improve urban mobility by offering solutions that facilitate the movement of people and goods, contributing to a more efficient and harmonious urban environment.

Velco

Venture Round in 2020
Velco SAS, founded in 2015 and based in Nantes, France, specializes in mobile applications that enhance bicycle security and navigation. The company's flagship product, Wink, is a handlebar device that connects to smartphones, enabling users to track their rides and prevent bike theft. In addition to security features, Velco aims to improve urban mobility by offering solutions that facilitate the movement of people and goods, contributing to a more efficient and harmonious urban environment.

Nextflow Software

Series A in 2020
Nextflow Software operates as an industry specific independent software vendor. It develops and sells computer – aided engineering software in the field of computations fluid dynamic (CFD). Its solution includes ditching and sloshing to aeronautic industry; fording river crossing, gearbox lubrication, hydroplaning, rain on windshield and sloshing to automotive industry; dam break and flooding solutions to energy & environment industry; drilling solutions to industrial processes; ship resistance, wave impact loads and sloshing to marine & offshore industry. Its product includes studio and solvers. Nextflow Software was founded in 2015 and is based in Nantes, France.

VitaDX

Venture Round in 2020
VitaDX International SA, founded in 2009 and based in Rennes, France, specializes in the early diagnosis of bladder cancer. The company leverages artificial intelligence and fluorescence imaging technology to enhance diagnostic accuracy. Its primary product, VisioCyt®, allows for bladder cancer detection through a simple urine sample, improving upon traditional urinary cytology methods. By utilizing advanced imaging and machine learning techniques, VitaDX's solutions enable pathologists and healthcare providers to identify potential bladder abnormalities early, facilitating timely diagnosis and treatment, which can lead to better patient outcomes.

Sight Diagnostics

Series D in 2020
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that focuses on developing advanced diagnostic solutions for blood diseases. Utilizing proprietary machine-vision technology, the company has created a platform that leverages artificial intelligence for blood analysis and infectious disease detection. Its flagship product, Parasight, is a malaria detection device that accurately identifies and enumerates malaria through a digital fluorescent microscopy process. Since its launch in 2014, Sight Diagnostics has sold over 600,000 tests across 25 countries. Additionally, the company has introduced OLO, a device that facilitates complete blood count testing at the point-of-care, which is currently available in the European Union and other non-US markets. By providing scalable and precise blood diagnostics, Sight Diagnostics aims to enhance patient outcomes and improve overall healthcare accessibility.

ABC Transfer

Series A in 2020
ABC Transfer is a biopharmaceutical company that specializes in the development of Rapid Transfer Systems (RTS) for the pharmaceutical industry. The company manufactures secure transfer systems designed specifically for sterile drug manufacturing and bioprocessing. Its innovative solutions include alpha doors, beta containers, and single-use bags, all built on patented designs. These systems enhance sterility assurance, improve operator safety, and increase overall efficiency in drug manufacturing processes. Through its focus on secure and efficient transfer methods, ABC Transfer aims to support the biopharmaceutical industry's critical need for reliable and safe drug production.

Quortex

Seed Round in 2020
Quortex, established in 2018 and located in Cesson-Sévigné, France, specializes in developing artificial intelligence-driven software solutions aimed at optimizing content delivery over the internet. The company focuses on enhancing video streaming services by leveraging advanced cloud technologies to adapt to varying network conditions, infrastructure capabilities, and audience demands. Its platform automatically adjusts cloud resources in real-time, ensuring an optimal user experience while significantly reducing infrastructure and network costs for clients. Through this innovative approach, Quortex aims to transform over-the-top (OTT) services, making them more efficient and cost-effective in an increasingly dynamic digital landscape.

Ecovelo

Venture Round in 2020
Developer of urban mobility technology designed for self-service electric bikes. The company offers eco-bikes that are sponsored by an advertiser and paid according to the kilometers traveled and hours of parking, all weighted according to the geolocation of the moment, enabling users and small and medium-sized communities to travel and earn by displaying the campaigns.

Energiency

Series A in 2020
Energiency is a software-as-a-service (SaaS) platform that specializes in energy performance assessment and management within industrial environments. The company has developed an artificial intelligence-driven energy analytics platform that detects and visualizes energy savings opportunities for manufacturing processes. This platform operates on both web and mobile interfaces, providing tools for monitoring, diagnostics, and continuous planning. By enabling industrial businesses to identify new energy savings opportunities, Energiency helps organizations optimize their energy performance and reduce carbon dioxide emissions.

Aviwest

Series B in 2020
Aviwest SAS is a prominent provider of digital video equipment and solutions tailored for the broadcast and security sectors. Established in 2008 and headquartered in Rennes, France, the company specializes in live and recorded video contribution systems that operate over bonded unmanaged IP networks, including cellular, Wi-Fi, satellite, and public internet. Its innovative products, driven by proprietary IP bonding technology, facilitate high-quality live video production for broadcasters, content producers, and TV stations, enabling seamless coverage of events like breaking news and live shows from remote locations. Additionally, Aviwest offers a range of services, including training, installation, customer support, and maintenance. Its solutions are also utilized in digital television, news gathering, surveillance, and military applications. With a global presence, Aviwest serves clients in over 160 countries, emphasizing innovation and customer service in its operations.

Shopopop

Venture Round in 2020
Shopopop is a collaborative delivery platform that facilitates the connection between individuals looking to deliver groceries and those in need of home delivery services. The platform allows users to turn their daily journeys into profitable opportunities by delivering items for others in exchange for a small fee. By linking vendors with customers, Shopopop aims to streamline the process of grocery delivery, ensuring that users receive their purchases conveniently at home without complications. This innovative approach not only enhances local commerce but also promotes a shared economy, benefiting both deliverers and recipients.

Acticor Biotech

Series B in 2019
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Robocath

Venture Round in 2019
Robocath, founded in 2009 by Philippe Bencteux, MD, specializes in designing, developing, and commercializing robotic solutions for cardiovascular disease treatment. The company has introduced R-One™, a robotic system that enhances the safety and precision of coronary angioplasty procedures by enabling specific movements and improving interventional conditions. R-One™ features an open architecture, making it compatible with leading devices and catheterization labs. Robocath is dedicated to advancing the field of vascular robotics and aims to lead in remote treatment solutions for vascular emergencies, ensuring optimal care pathways for patients.

Abyss Ingredients

Seed Round in 2019
Abyss Ingredients specializes in manufacturing marine biotechnological ingredients aimed at providing essential nutrients for various age groups, including infants, children, and adults. The company focuses on developing natural health ingredients derived from sustainable marine bio-resources, ensuring innovation and sustainability in its processes. Abyss Ingredients offers products that support joint health, metabolic syndrome, anti-inflammatory needs, cardiovascular protection, digestive health, immunomodulation, skin health, and brain health. With a commitment to healthy aging, the company enables nutraceutical and nutri-cosmetic firms to create effective and distinctive products tailored to enhance health and well-being. Established in 2004, Abyss Ingredients is headquartered in Caudan, France, with additional locations in Quimper and Lorient, and serves both local and international markets.

Igyxos

Series A in 2019
Igyxos S.A., founded in 2017 and based in Nouzilly, France, focuses on developing innovative pharmaceuticals and medical technologies aimed at improving human fertility. The company engages in all stages of drug development, from discovering promising targets to identifying lead compounds, including small molecules and antibodies. Igyxos specializes in monoclonal antibodies that enhance the activity of gonadotropins and hormones critical for reproduction. Additionally, the company supports the transition of potential drug candidates through the pre-clinical and clinical phases of development, aiming to address the increasing global demand for effective infertility solutions for both men and women.

Graftys

Series A in 2019
Graftys SAS, based in Aix-en-Provence, France, specializes in the design, development, and manufacturing of synthetic bone biomaterials aimed at reconstructive orthopedic surgery. Founded in 2005, the company provides a range of innovative products, including Graftys QuickSet, a calcium phosphate cement with properties akin to cancellous bone, and biphasic calcium phosphates used for bone repair in surgical procedures. Other offerings include BioActys Granule and Graftys HBS, a cement that transforms into a plastic paste when mixed with a liquid phase. Graftys' products are utilized in various medical applications, such as the fixation of endoprostheses, treatment of bone tumors, and procedures in dentistry and oral surgery, including pulp protection and bone regeneration support.

Sight Diagnostics

Series C in 2019
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that focuses on developing advanced diagnostic solutions for blood diseases. Utilizing proprietary machine-vision technology, the company has created a platform that leverages artificial intelligence for blood analysis and infectious disease detection. Its flagship product, Parasight, is a malaria detection device that accurately identifies and enumerates malaria through a digital fluorescent microscopy process. Since its launch in 2014, Sight Diagnostics has sold over 600,000 tests across 25 countries. Additionally, the company has introduced OLO, a device that facilitates complete blood count testing at the point-of-care, which is currently available in the European Union and other non-US markets. By providing scalable and precise blood diagnostics, Sight Diagnostics aims to enhance patient outcomes and improve overall healthcare accessibility.

Monemprunt

Seed Round in 2018
Monemprunt.com is a digital brokerage firm specializing in real estate credit, founded in 2016 and based in Rennes, France. The platform operates as a direct exchange between borrowers and banks, offering a streamlined and online process for securing competitive loan rates. Monemprunt.com aims to simplify the mortgage application journey by providing borrowers with the tools and advice needed to manage their loan applications independently. The firm negotiates favorable terms on behalf of its clients, ensuring a faster response time and centralized information to aid decision-making. Catering to both individuals and professionals, Monemprunt.com addresses the evolving needs of a tech-savvy clientele seeking efficient financing solutions for their real estate projects.

Milestone Pharmaceuticals

Series D in 2018
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, focused on the development and commercialization of etripamil, a novel calcium channel blocker targeting various cardiovascular conditions. Etripamil is designed as a rapid-onset nasal spray for the self-administration by patients, specifically to terminate episodes of paroxysmal supraventricular tachycardia (PSVT). The company is currently advancing etripamil through Phase III clinical trials for PSVT in the United States and Canada, as well as conducting Phase II trials for patients with atrial fibrillation experiencing a rapid ventricular rate. Founded in 2003, Milestone aims to address unmet medical needs in the treatment of transient cardiovascular conditions, including atrial fibrillation and angina.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Shopopop

Venture Round in 2018
Shopopop is a collaborative delivery platform that facilitates the connection between individuals looking to deliver groceries and those in need of home delivery services. The platform allows users to turn their daily journeys into profitable opportunities by delivering items for others in exchange for a small fee. By linking vendors with customers, Shopopop aims to streamline the process of grocery delivery, ensuring that users receive their purchases conveniently at home without complications. This innovative approach not only enhances local commerce but also promotes a shared economy, benefiting both deliverers and recipients.

Velco

Venture Round in 2018
Velco SAS, founded in 2015 and based in Nantes, France, specializes in mobile applications that enhance bicycle security and navigation. The company's flagship product, Wink, is a handlebar device that connects to smartphones, enabling users to track their rides and prevent bike theft. In addition to security features, Velco aims to improve urban mobility by offering solutions that facilitate the movement of people and goods, contributing to a more efficient and harmonious urban environment.

TRiCares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

ideolys

Venture Round in 2018
Ideolys SAS specializes in web-based software solutions tailored for the catering industry. Founded in 2010 and headquartered in La Roche sur Yon, France, the company offers Easilys, an online application designed for the management of catering operations in business and industry, education, and healthcare sectors. Additionally, Ideolys provides Easilys Commandes Convives, a customer portal that facilitates the management of remote kitchen sites and home delivery services. The company also offers training, support, hosting, and project management services to enhance its software solutions.

Vite mon Marché

Seed Round in 2018
Vite Mon Marché offers urban / Nantes delivery in less than one hour of fresh and local products directly to the home (fruit, vegetables, meat, fish, dairy, drinks ...). Discovered from producers in the outskirts of Nantes, hundreds of fresh and high quality farm produce (organic or not) are offered every day of the week.

Turbotech

Venture Round in 2018
TURBOTECH S.A.S develops energy storage system for aircraft. The company offers turboprops and turbo electric generators for light aircraft which combines recuperated turbine with electric machine. The company was founded in 2017 and is headquartered in Toussus-Le-Noble, France.

Biosency

Seed Round in 2018
BIOSENCY SAS designs and manufactures medical devices. The company manufactures PPG sensor system that monitors and prevents solution dedicated to respiratory insufficiency. It measures cardio-respiratory parameters at rest and in outpatient efforts. The device provides telemonitoring, prediction, prevention of respiratory insufficiency, and facilitates clinical management. BIOSENCY SAS was founded in 2017 and is based in Cesson-Sévigné, France.

Blacknut

Seed Round in 2018
Blacknut SAS, founded in 2016 and headquartered in Cesson-Sévigné, France, specializes in cloud gaming services aimed at consumers and businesses. The company provides a subscription-based platform that features an extensive catalog of over 400 premium video games, suitable for all ages. Blacknut's service is accessible across various devices, including mobile phones, set-top boxes, and Smart TVs, making it available in Europe, Asia, and North America. The platform utilizes an algorithm to tailor game recommendations based on user preferences, facilitating real-time discovery and play. With a focus on user experience, Blacknut aims to revolutionize the distribution of video games while fostering a community for players to share their gaming experiences.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, established in 2006. It specializes in the research and development of lytic bacteriophages, which are natural predators of bacteria, for therapeutic and diagnostic applications, particularly in addressing antibiotic resistance. The company has developed several banks of bacteriophages, including a collection targeting Escherichia coli. Pherecydes Pharma is engaged in innovative approaches to personalized phage therapy, aiming to treat bacterial infections by launching multicenter European trials, such as those evaluating phage therapy for infected burn wounds. This therapeutic strategy allows for the detection and treatment of a wide range of bacterial infections, including multi-resistant and emergent strains, without affecting human cells.

BodyCap

Series A in 2017
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Seaver

Seed Round in 2017
Seaver SAS is a technology startup based in Caen, France, focused on developing connected girth products for monitoring horse health and performance. Founded in 2016, the company offers innovative devices that track vital metrics such as heart and respiratory rates, calories burned, gait, and jump performance. These connected girths provide real-time data to horse owners and coaches, enhancing their ability to monitor training and overall equine health. Additionally, Seaver has developed a mobile application that complements its hardware by allowing users to access and analyze the data collected from the girth. Through these advancements, Seaver aims to digitalize the equestrian experience, enabling better training outcomes and health management for horses.

Horama SAS

Series B in 2017
Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Milestone Pharmaceuticals

Series C in 2017
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, focused on the development and commercialization of etripamil, a novel calcium channel blocker targeting various cardiovascular conditions. Etripamil is designed as a rapid-onset nasal spray for the self-administration by patients, specifically to terminate episodes of paroxysmal supraventricular tachycardia (PSVT). The company is currently advancing etripamil through Phase III clinical trials for PSVT in the United States and Canada, as well as conducting Phase II trials for patients with atrial fibrillation experiencing a rapid ventricular rate. Founded in 2003, Milestone aims to address unmet medical needs in the treatment of transient cardiovascular conditions, including atrial fibrillation and angina.

Wexity

Seed Round in 2017
Wexity is a company that specializes in developing urban management solutions tailored for small and medium-sized cities. Founded in 2017 and based in Nantes, France, Wexity offers a digital city management platform designed to assist local government officials in addressing the complex challenges of urbanization. The platform facilitates investment planning, evaluates the impacts of growth forecasts, and assesses climate and industrial risks. By analyzing urban data, Wexity provides insights into environmental and infrastructure impacts, helping city executives to create prevention plans and generate comprehensive reports. With a focus on high-growth regions such as Africa, India, and the Middle East, Wexity aims to deliver affordable and user-friendly solutions to support effective city management as urban populations continue to rise.

Highcon

Series F in 2017
Highcon delivers innovation and differentiation that converters, printers, and brand owners all need, transforming “finishing” into a value adding process to positively impact users’ profitability by increasing speed to market, eliminating costly production steps and reducing carbon footprint. The Highcon Euclid is the first fully digital cutting and creasing machine for converting paper, labels, folding carton and microflute. The Euclid incorporates Highcon’s patented ‘DART’ (Digital Adhesive Rule Technology) to produce creases, and high-speed laser optics to for cutting and etching. Contact info +972-8-9101705 web site: www.highcon.net

VitaDX

Seed Round in 2017
VitaDX International SA, founded in 2009 and based in Rennes, France, specializes in the early diagnosis of bladder cancer. The company leverages artificial intelligence and fluorescence imaging technology to enhance diagnostic accuracy. Its primary product, VisioCyt®, allows for bladder cancer detection through a simple urine sample, improving upon traditional urinary cytology methods. By utilizing advanced imaging and machine learning techniques, VitaDX's solutions enable pathologists and healthcare providers to identify potential bladder abnormalities early, facilitating timely diagnosis and treatment, which can lead to better patient outcomes.

Robocath

Venture Round in 2017
Robocath, founded in 2009 by Philippe Bencteux, MD, specializes in designing, developing, and commercializing robotic solutions for cardiovascular disease treatment. The company has introduced R-One™, a robotic system that enhances the safety and precision of coronary angioplasty procedures by enabling specific movements and improving interventional conditions. R-One™ features an open architecture, making it compatible with leading devices and catheterization labs. Robocath is dedicated to advancing the field of vascular robotics and aims to lead in remote treatment solutions for vascular emergencies, ensuring optimal care pathways for patients.

SWEETCH Energy

Venture Round in 2017
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

ComparateurAgricole.com

Series A in 2017
ComparateurAgricole.com aims to valorize farmers' stocks by offering the best prices in cereals (wheat, barley, corn ...) and oilseeds (rapeseed). The activity has extended to the supply of fertilizers following the demand of the farmers customers, always with the objective to guarantee the best quality / price ratio. All prices are transparent and accessible in a few clicks. The headquarters of the company is located on the family farm in GOHORY. We made the choice to stay in Beauce, granary of France, to be close to our farmers. For several months, the offices are located in Chartres, in the city of innovation, an innovative business incubator.

i-SEP

Venture Round in 2017
i-SEP is a French Medtech company focused on auto-transfusion and Patient Blood Management. It has developed innovative technology for the separation of blood components, aiming to be the first French start-up to market a self-transfusion system that can recover both red blood cells and platelets during hemorrhagic surgical procedures. The company's intraoperative blood auto-transfusers are designed to aid surgical operations by recovering, treating, concentrating, and re-transfusing patients' own blood. This approach minimizes the risks associated with blood compatibility and contamination, while also reducing the likelihood of postoperative complications. i-SEP collaborates closely with surgical teams to enhance patient outcomes, streamline practitioner workflows, and help lower hospital costs.

SurfactGreen

Venture Round in 2017
Surfact'Green is a company that specializes in the development and production of patented ecological surfactants derived from agro-resources such as algae and sugar beet co-products. Established as a business unit in 2011 at the Rennes National School of Chemistry, it builds on over a decade of research conducted by the Organic and Supramolecular Chemistry team. The company focuses on creating green chemistry solutions that replace products derived from petrochemistry with eco-compatible, biodegradable alternatives. Surfact'Green's surfactants are formulated to be solvent-free, sulfate-free, and readily biodegradable, allowing businesses to reduce their environmental and human health impacts. The company collaborates with various public and private laboratories, as well as industrial partners, to advance its innovations in sustainable surfactant production.

Energiency

Series A in 2017
Energiency is a software-as-a-service (SaaS) platform that specializes in energy performance assessment and management within industrial environments. The company has developed an artificial intelligence-driven energy analytics platform that detects and visualizes energy savings opportunities for manufacturing processes. This platform operates on both web and mobile interfaces, providing tools for monitoring, diagnostics, and continuous planning. By enabling industrial businesses to identify new energy savings opportunities, Energiency helps organizations optimize their energy performance and reduce carbon dioxide emissions.

QOS ENERGY

Venture Round in 2017
QOS ENERGY operates as a software vendor that specializes in energy management systems. The company develops and commercializes Qantum, a Software-as-a-Service solution for the monitoring and management of renewable energy infrastructures. It serves the specific requirements of professional energy performance managers, including medium and large size photovoltaic, wind, hydraulic, and biogas plants; energy efficiency in buildings and industry; and eco-territories and smartgrid projects of various sizes in Europe. The company was founded in 2010 and is based in La Chapelle sur Erdre, France with an additional office in the United Kingdom. QOS ENERGY operates as a subsidiary of The Astelia Group.

Malkyrs

Venture Round in 2016
Malkyrs Studio offers the opportunity to play a game of physical cards retaining the improvements acquired during the dematerialization of the game on the Internet while enjoying the virtues of the traditional board game. Thus it was possible for us to imagine a game of cards before any physical but proposing an unprecedented digital interaction enriching the experience of the players.

EasyBroadcast

Seed Round in 2016
EasyBroadcast is a company headquartered at the Ecole Centrale de Nantes that specializes in developing a video content delivery platform. This platform is designed to enhance the efficiency of bandwidth usage for streaming audio and video content, including Video on Demand (VOD) and Subscription Video on Demand (SVOD) services. By optimizing bandwidth consumption, EasyBroadcast improves the quality of streamed content, allowing broadcasters and enterprises to effectively monetize their offerings through custom banner advertisements. The company aims to expand audience reach across multiple devices, making it a versatile solution for content providers in the digital streaming landscape.

Sabella

Venture Round in 2016
Sabella SAS is an engineering and project management firm based in Quimper, France, specializing in marine energies. Founded in 2008, the company develops submarine tidal stream turbines designed to generate hydrokinetic energy. Sabella supplies reliable turnkey energy solutions worldwide, focusing on a differentiated and economically optimized range of technologies. These innovations are protected by patents and aim to support a new energy model specifically for remote grids on islands and isolated coastal communities.

InFlectis BioScience

Series A in 2016
InFlectis BioScience is a drug discovery company based in Nantes, France, established in 2013. The company specializes in developing small molecule drugs that target the unfolded protein response, aiming to address misfolded protein disorders linked to neurodegenerative and age-related diseases. By focusing on the cellular defense system against misfolded proteins, InFlectis BioScience seeks to modulate key proteins involved in maintaining endoplasmic reticulum (ER) proteostasis, which is essential for cellular function and survival. The company’s innovative approach helps to safeguard cellular integrity by managing ER stress, a condition that arises when the folding capacity of the ER is compromised. Through its research and development efforts, InFlectis BioScience strives to advance preclinical-stage products that can enhance patient care while maximizing the commercial potential of its offerings.

Kemwatt SAS

Private Equity Round in 2016
Kemwatt SAS designs, develops, manufactures, and markets batteries with circulating electrolytes for application in stationary storage of electricity to facilitate the management of the network within the framework of renewable electrical production.

Dictanova

Venture Round in 2016
Founded in 2011 by Fabien Poulard (PhD in Computer Science, automated language processing), Dictanova has developed a cloud based platform that provides text analytics and sentiment analysis services, for all companies who need to understand their customers. This platform allows marketing and customer experience professionals to explore and analyze thousand of client feedbacks in a few minutes. Customer feedback analysis provides keys to understand clients needs, and identify the subjects of tension in the customer experience as well as the delighting factors.

i-SEP

Seed Round in 2015
i-SEP is a French Medtech company focused on auto-transfusion and Patient Blood Management. It has developed innovative technology for the separation of blood components, aiming to be the first French start-up to market a self-transfusion system that can recover both red blood cells and platelets during hemorrhagic surgical procedures. The company's intraoperative blood auto-transfusers are designed to aid surgical operations by recovering, treating, concentrating, and re-transfusing patients' own blood. This approach minimizes the risks associated with blood compatibility and contamination, while also reducing the likelihood of postoperative complications. i-SEP collaborates closely with surgical teams to enhance patient outcomes, streamline practitioner workflows, and help lower hospital costs.

Alcuin

Funding Round in 2015
Alcuin SAS is a software development company specializing in talent and training management solutions. Founded in 2013 and based in Beaucouzé, France, with an additional office in Paris, Alcuin provides a comprehensive range of human capital management services. These include talent assessments, recruitment portals, employee and manager portals, performance reviews, training plan development, and strategic workforce planning. The company serves a diverse clientele across various sectors, including banking, insurance, health, transport, energy, media, and the public sector. In addition to corporate learning management, which encompasses sales management and training portfolio organization, Alcuin also offers campus learning management solutions tailored for educational institutions. This includes program design, admissions, accreditation, and internship management. Alcuin’s software is designed to address the training and human resources management needs of businesses, training organizations, and higher education institutions, both in France and internationally. Alcuin operates as a subsidiary of Total Specific Solutions.

Ergosup

Series A in 2015
Ergosup is a company based in Malataverne, France, that specializes in the development of decentralized hydrogen-energy production systems. The firm has created an innovative process for producing high-pressure hydrogen on-site, which facilitates the refueling of hydrogen fuel vehicles. Ergosup provides generators that store and convert electricity into hydrogen under pressure, enabling the co-generation of electric power for hydrogen service stations and various industrial applications. This technology allows clients to achieve zero-emission solutions for mobility applications, contributing to a more sustainable energy future.

Qowisio

Venture Round in 2015
Qowisio SAS is an IoT solution provider based in Angers, France, with additional offices in Austin, Texas, and Paris. Founded in 2009, the company specializes in low-cost, low-power cellular networks for IoT applications, focusing on low-bandwidth connectivity for wireless devices. Qowisio offers a diverse range of connected devices and technological solutions tailored to various use cases, including tracking, power monitoring, environment monitoring, security monitoring, pallet tracking, and temperature monitoring for buildings and commercial refrigerators. Its products are designed to enhance productivity and enable clients, including small to medium-sized businesses and larger enterprises, to create new revenue streams through improved connectivity and data integration.

VitamFero

Series C in 2015
VitamFero SA is a biotechnology company based in Angers, France, that specializes in the development and marketing of prophylactic agents, particularly vaccines and neonatal immunostimulants, aimed at treating various infectious diseases. Founded in 2005, the company utilizes its patented Toxo Mic1-3KO technology to create innovative vaccines targeting Apicomplexe parasites. Its product line includes vaccines such as VFOtx-251 for ovine toxoplasmosis, VFOne-273 for bovine neosporosis, and VFOlh-211 for canine leishmaniasis and equine protozoal myeloencephalitis. With a focus primarily on veterinary healthcare, VitamFero is dedicated to addressing the challenges posed by these infectious agents, thereby improving animal health outcomes.

Digitaleo

Venture Round in 2015
Digitaleo SAS provides digital marketing solutions. The company offers a cloud marketing platform to companies and sales outlets, enabling them to manage their digital marketing procedures in real time via text message, mobile Websites/QR codes, email, voice messages, social networks, and touch screen tablets. It offers database solution that enables to collect customers' contact details; multi-channel relationship marketing solution, which allows users to communicate on various digital channels, such as Web, mobile, and social channels; and solutions to create and manage satisfaction surveys. Digitaleo serves industries, such as retail; ready-to-wear – beauty; automotive; restaurants and hotels; leisure – tourism; education - high education- employment; and agencies – publishers worldwide. The company was formerly known as Digital Media and changed its name to Digitaleo SAS in January 2010. The company was incorporated in 2003 and is based in Rennes, France.

EffiNov Laboratory

Venture Round in 2015
EffiNov Nutrition S.A.S. is a French laboratory based in Lorient that specializes in micronutrition. Founded in 2010, the company manufactures a wide array of vitamin supplements and dietary products aimed at enhancing overall health and well-being. EffiNov develops and markets personalized food and nutrition plans tailored to address various health concerns, including digestive disorders, emotional stress, sleep issues, joint pain, weight loss, and pregnancy. The company emphasizes the use of natural ingredients in compliance with European regulations, ensuring safety and efficacy in its products. Through its software nutritional analysis, EffiNov provides diet programs designed to optimize the nutritional balance for individuals, promoting improved health and vitality.

Qivivo

Venture Round in 2015
Qivivo is an energy savings provider focused on helping households manage their energy bills more effectively. Recognizing that heating constitutes a significant portion of energy costs, Qivivo offers an intelligent thermostat designed to optimize home temperature settings, potentially reducing energy consumption by up to 25%. The system utilizes automation and artificial intelligence to personalize heating management, ensuring comfort while minimizing waste. By connecting directly to a home's heating system, Qivivo’s solution adjusts temperatures automatically, allowing users to maintain ideal conditions without sacrificing comfort or incurring high energy costs.

Diafir

Venture Round in 2015
Diafir develops and manufactures biological testing systems that utilize unique infrared fiber sensor technology for rapid biological analysis. Founded in 2011 and based in Rennes, France, the company focuses on in situ analytical tools that serve key applications in point-of-care medical diagnostics, food analysis, and the monitoring of organic chemical reactions. Diafir's systems are designed to quickly detect conditions such as chronic liver disease, infections, and tumors, achieving results in as little as five minutes. The company's innovative approach leverages chalcogenide fiberglass, enabling effective infrared light transmission for precise and efficient biological analysis.

InFlectis BioScience

Seed Round in 2015
InFlectis BioScience is a drug discovery company based in Nantes, France, established in 2013. The company specializes in developing small molecule drugs that target the unfolded protein response, aiming to address misfolded protein disorders linked to neurodegenerative and age-related diseases. By focusing on the cellular defense system against misfolded proteins, InFlectis BioScience seeks to modulate key proteins involved in maintaining endoplasmic reticulum (ER) proteostasis, which is essential for cellular function and survival. The company’s innovative approach helps to safeguard cellular integrity by managing ER stress, a condition that arises when the folding capacity of the ER is compromised. Through its research and development efforts, InFlectis BioScience strives to advance preclinical-stage products that can enhance patient care while maximizing the commercial potential of its offerings.

BodyCap

Venture Round in 2015
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

QOS ENERGY

Venture Round in 2014
QOS ENERGY operates as a software vendor that specializes in energy management systems. The company develops and commercializes Qantum, a Software-as-a-Service solution for the monitoring and management of renewable energy infrastructures. It serves the specific requirements of professional energy performance managers, including medium and large size photovoltaic, wind, hydraulic, and biogas plants; energy efficiency in buildings and industry; and eco-territories and smartgrid projects of various sizes in Europe. The company was founded in 2010 and is based in La Chapelle sur Erdre, France with an additional office in the United Kingdom. QOS ENERGY operates as a subsidiary of The Astelia Group.

VitamFero

Funding Round in 2014
VitamFero SA is a biotechnology company based in Angers, France, that specializes in the development and marketing of prophylactic agents, particularly vaccines and neonatal immunostimulants, aimed at treating various infectious diseases. Founded in 2005, the company utilizes its patented Toxo Mic1-3KO technology to create innovative vaccines targeting Apicomplexe parasites. Its product line includes vaccines such as VFOtx-251 for ovine toxoplasmosis, VFOne-273 for bovine neosporosis, and VFOlh-211 for canine leishmaniasis and equine protozoal myeloencephalitis. With a focus primarily on veterinary healthcare, VitamFero is dedicated to addressing the challenges posed by these infectious agents, thereby improving animal health outcomes.

Atlanthera

Venture Round in 2014
Atlanthera is a research and development company focused on innovative therapeutic strategies for treating bone tumors and metastases. It has developed a drug discovery platform that utilizes new chemical molecules designed to target bone tissue specifically. This platform allows for the vectorization of active pharmaceutical ingredients, enabling the precise delivery of high concentrations of these molecules directly to bone tumors. By concentrating treatment locally, Atlanthera aims to minimize systemic adverse effects, offering healthcare professionals novel options for managing bone tumor-related conditions.

Aqualeg

Seed Round in 2013
Aqualeg is a company has invented and produces skin-friendly silicone leg prosthesis liners that allow patients to use water in the water, unlike all existing skincare products.

BodyCap

Venture Round in 2013
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Carlina Technologies

Equity Crowdfunding in 2012
Carlina Technologies S.A.S., founded in 2010 and based in Angers, France, specializes in the development of micro and nanomedicines aimed at improving patient outcomes. The company focuses on innovative drug delivery systems, including liposomes, micelles, microspheres, and micro and nanoemulsions, that enhance the therapeutic efficacy of small molecules and therapeutic proteins. In addition to its core offerings, Carlina provides comprehensive formulation development services such as pre-formulation, process manufacturing, and analytical method development. The company serves various sectors, including pharmaceuticals, biotechnology, and veterinary medicine, utilizing advanced encapsulation processes to improve drug compliance and quality of life for patients suffering from diverse diseases. Founded through collaboration between prominent figures in pharmaceutical sciences, Carlina Technologies has established itself as a key player in the biotechnology field.

EffiNov Laboratory

Seed Round in 2012
EffiNov Nutrition S.A.S. is a French laboratory based in Lorient that specializes in micronutrition. Founded in 2010, the company manufactures a wide array of vitamin supplements and dietary products aimed at enhancing overall health and well-being. EffiNov develops and markets personalized food and nutrition plans tailored to address various health concerns, including digestive disorders, emotional stress, sleep issues, joint pain, weight loss, and pregnancy. The company emphasizes the use of natural ingredients in compliance with European regulations, ensuring safety and efficacy in its products. Through its software nutritional analysis, EffiNov provides diet programs designed to optimize the nutritional balance for individuals, promoting improved health and vitality.

Diafir

Seed Round in 2012
Diafir develops and manufactures biological testing systems that utilize unique infrared fiber sensor technology for rapid biological analysis. Founded in 2011 and based in Rennes, France, the company focuses on in situ analytical tools that serve key applications in point-of-care medical diagnostics, food analysis, and the monitoring of organic chemical reactions. Diafir's systems are designed to quickly detect conditions such as chronic liver disease, infections, and tumors, achieving results in as little as five minutes. The company's innovative approach leverages chalcogenide fiberglass, enabling effective infrared light transmission for precise and efficient biological analysis.

Neosteo

Seed Round in 2012
Neosteo SAS is a French company based in Nantes that specializes in the design and production of advanced implant technologies and instrument kits for orthopedic surgery. Founded in 2010, Neosteo focuses on developing innovative solutions aimed at simplifying osteotomy and trauma surgeries. Their product offerings include FlexitSystem plates for knee osteotomy, as well as a range of implant technologies and kits designed for high tibial osteotomy and femoral osteotomy procedures. These kits comprise osteosynthesis plates, locking screws, surgical guides, and other essential instruments, facilitating efficient surgical practices and promoting immediate post-operative recovery for patients.

La société LENTILLES

Seed Round in 2011
The company LENTILLES (LCS) is a laboratory specialized in contactology. The Caen-based company has developed a patented process for producing hybrid contact lenses (using flexible polymers and rigid polymers). Laboratoire LCS is a French contact lens manufacturing laboratory , located in Normandy. LCS services a variety of vision needs and supplies ophthalmologists and opticians with a wide range of tailor made rigid and soft lenses.

Neli Technologies

Series B in 2010
NELI Technologies is developing a solution for broadcasting digital terrestrial television throughout the home using powerline communication technology.

IRIS-RFID

Venture Round in 2009
IRIS-RFID is a private French company established in Paris in August 2007. Their founding engineers have more than 40 years experience in total in the development and implementation of innovative RFID solutions internationally (Canada, United States, Brazil, France, Asia, Africa, etc.).

Augure

Series D in 2008
Augure, founded in 2002 in Paris, specializes in influencer marketing software that aids brands and agencies in integrating traditional public relations with modern influencer strategies. The platform is utilized by over 1,000 communication, PR, and public affairs teams daily, enabling them to engage relevant influencers, manage campaigns, and enhance their media presence and reputation across social networks. Augure's data services team complements its software offerings by providing consulting support, helping clients interpret data to refine their influencer marketing approaches. The company operates in Europe and Latin America, serving a diverse clientele that includes major organizations such as Orange, Thales, and Château de Versailles.

Seadev-FermenSys

Venture Round in 2007
Seadev-FermenSys is the exclusive operator of extremophile marine bacteria collections including IFREMER marine hydrothermophilic strains commercialized under an exclusive Trade License.

Carlipa

Series C in 2007
Carlipa Systems offers automated multimedia communication solutions. The company’s products include Kast Engine©, a software engine for real time diffusion and NMG ® that allows automatic control of video and audio flows. These products are used for marketing of point of sale and television of company. Carlipa Systems was founded in 2002 and is based in Saint Nom la Bretèche, France.

Augure

Series C in 2006
Augure, founded in 2002 in Paris, specializes in influencer marketing software that aids brands and agencies in integrating traditional public relations with modern influencer strategies. The platform is utilized by over 1,000 communication, PR, and public affairs teams daily, enabling them to engage relevant influencers, manage campaigns, and enhance their media presence and reputation across social networks. Augure's data services team complements its software offerings by providing consulting support, helping clients interpret data to refine their influencer marketing approaches. The company operates in Europe and Latin America, serving a diverse clientele that includes major organizations such as Orange, Thales, and Château de Versailles.

Carlipa

Series B in 2005
Carlipa Systems offers automated multimedia communication solutions. The company’s products include Kast Engine©, a software engine for real time diffusion and NMG ® that allows automatic control of video and audio flows. These products are used for marketing of point of sale and television of company. Carlipa Systems was founded in 2002 and is based in Saint Nom la Bretèche, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.